CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death
Constitutive activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is a hallmark of many lymphocyte-associated cancers, including cutaneous T-cell lymphoma (CTCL) and its leukemic variant, the Sézary syndrome. Dimethyl fumarate (DMF) has been identified as...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2025
|
| In: |
The FEBS journal
Year: 2025, Pages: 1-17 |
| ISSN: | 1742-4658 |
| DOI: | 10.1111/febs.70208 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1111/febs.70208 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/febs.70208 |
| Author Notes: | Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller and Karsten Gülow |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1939738083 | ||
| 003 | DE-627 | ||
| 005 | 20251103144211.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251030s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/febs.70208 |2 doi | |
| 035 | |a (DE-627)1939738083 | ||
| 035 | |a (DE-599)KXP1939738083 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Teubner, Jan P. |e VerfasserIn |0 (DE-588)1380308585 |0 (DE-627)1939740339 |4 aut | |
| 245 | 1 | 0 | |a CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death |c Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller and Karsten Gülow |
| 264 | 1 | |c 2025 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Erstmals veröffentlicht: 1. August 2025 | ||
| 500 | |a Gesehen am 30.10.2025 | ||
| 520 | |a Constitutive activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is a hallmark of many lymphocyte-associated cancers, including cutaneous T-cell lymphoma (CTCL) and its leukemic variant, the Sézary syndrome. Dimethyl fumarate (DMF) has been identified as a promising NF-κB-targeted therapy and has shown positive outcomes in a phase II clinical trial involving patients with Sézary syndrome. However, limited responsiveness remains a significant challenge. Through a genome-wide clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 screen, we identified enhancer of zeste homolog 2 (EZH2; also known as histone-lysine N-methyltransferase) as a critical target for enhancing DMF-induced cell death. EZH2, the catalytic subunit of Polycomb Repressive Complex 2 (PRC2), is responsible for the methylation of histone H3 (H3K27). Combining DMF with the US Food and Drug Administration (FDA)-approved EZH2 inhibitor tazemetostat significantly increases cell death in patient-derived CTCL cells, offering a promising strategy to improve therapeutic outcomes and overcome limited responsiveness to DMF. | ||
| 650 | 4 | |a dimethyl fumarate (DMF) | |
| 650 | 4 | |a EZH2 | |
| 650 | 4 | |a histone methylation | |
| 650 | 4 | |a lymphoma | |
| 650 | 4 | |a Polycomb Repressive Complex 2 (PRC2) | |
| 700 | 1 | |a Tümen, Deniz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kandulski, Arne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heumann, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mester, Patricia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aschenbrenner, Elisabeth |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pollinger, Kirstin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gunckel, Manuela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Volz, Barbara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hein, Tobias |d 1989- |e VerfasserIn |0 (DE-588)120887697X |0 (DE-627)1695832477 |4 aut | |
| 700 | 1 | |a Beltzig, Paul L. |d 1995- |e VerfasserIn |0 (DE-588)1364687461 |0 (DE-627)1924741121 |4 aut | |
| 700 | 1 | |a Tengler, Luisa |d 1994- |e VerfasserIn |0 (DE-588)1327057050 |0 (DE-627)1886565953 |4 aut | |
| 700 | 1 | |a Voll, Florian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kreutz, Marina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kunst, Claudia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nicolay, Jan Peter |d 1981- |e VerfasserIn |0 (DE-588)138614474 |0 (DE-627)604867352 |0 (DE-576)308046188 |4 aut | |
| 700 | 1 | |a Müller-Schilling, Martina |e VerfasserIn |0 (DE-588)1075470811 |0 (DE-627)833291130 |0 (DE-576)184003237 |4 aut | |
| 700 | 1 | |a Gülow, Karsten |e VerfasserIn |0 (DE-588)1075033322 |0 (DE-627)832872008 |0 (DE-576)184768748 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a Vereinigung der Europäischen Biochemischen Gesellschaften |t The FEBS journal |d Oxford [u.a.] : Wiley-Blackwell, 2005 |g (2025), Seite 1-17 |h Online-Ressource |w (DE-627)476538459 |w (DE-600)2172518-4 |w (DE-576)115515283 |x 1742-4658 |7 nnas |
| 773 | 1 | 8 | |g year:2025 |g pages:1-17 |g extent:17 |a CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death |
| 856 | 4 | 0 | |u https://doi.org/10.1111/febs.70208 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/febs.70208 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251030 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1075033322 |a Gülow, Karsten |m 1075033322:Gülow, Karsten |d 50000 |e 50000PG1075033322 |k 0/50000/ |p 18 |y j | ||
| 998 | |g 138614474 |a Nicolay, Jan Peter |m 138614474:Nicolay, Jan Peter |d 60000 |d 61900 |e 60000PN138614474 |e 61900PN138614474 |k 0/60000/ |k 1/60000/61900/ |p 16 | ||
| 998 | |g 1327057050 |a Tengler, Luisa |m 1327057050:Tengler, Luisa |d 60000 |d 61900 |d 60000 |e 60000PT1327057050 |e 61900PT1327057050 |e 60000PT1327057050 |k 0/60000/ |k 1/60000/61900/ |k 0/60000/ |p 12 | ||
| 998 | |g 1364687461 |a Beltzig, Paul L. |m 1364687461:Beltzig, Paul L. |d 60000 |d 61900 |e 60000PB1364687461 |e 61900PB1364687461 |k 0/60000/ |k 1/60000/61900/ |p 11 | ||
| 998 | |g 120887697X |a Hein, Tobias |m 120887697X:Hein, Tobias |d 60000 |e 60000PH120887697X |k 0/60000/ |p 10 | ||
| 999 | |a KXP-PPN1939738083 |e 479458332X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"17 S."}],"person":[{"roleDisplay":"VerfasserIn","family":"Teubner","display":"Teubner, Jan P.","role":"aut","given":"Jan P."},{"display":"Tümen, Deniz","role":"aut","given":"Deniz","roleDisplay":"VerfasserIn","family":"Tümen"},{"roleDisplay":"VerfasserIn","family":"Kandulski","given":"Arne","display":"Kandulski, Arne","role":"aut"},{"given":"Philipp","role":"aut","display":"Heumann, Philipp","roleDisplay":"VerfasserIn","family":"Heumann"},{"family":"Mester","roleDisplay":"VerfasserIn","display":"Mester, Patricia","role":"aut","given":"Patricia"},{"roleDisplay":"VerfasserIn","family":"Aschenbrenner","display":"Aschenbrenner, Elisabeth","role":"aut","given":"Elisabeth"},{"given":"Kirstin","role":"aut","display":"Pollinger, Kirstin","family":"Pollinger","roleDisplay":"VerfasserIn"},{"family":"Gunckel","roleDisplay":"VerfasserIn","given":"Manuela","role":"aut","display":"Gunckel, Manuela"},{"role":"aut","display":"Volz, Barbara","given":"Barbara","roleDisplay":"VerfasserIn","family":"Volz"},{"display":"Hein, Tobias","role":"aut","given":"Tobias","family":"Hein","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Beltzig","given":"Paul L.","role":"aut","display":"Beltzig, Paul L."},{"family":"Tengler","roleDisplay":"VerfasserIn","display":"Tengler, Luisa","role":"aut","given":"Luisa"},{"roleDisplay":"VerfasserIn","family":"Voll","role":"aut","display":"Voll, Florian","given":"Florian"},{"family":"Kreutz","roleDisplay":"VerfasserIn","given":"Marina","role":"aut","display":"Kreutz, Marina"},{"roleDisplay":"VerfasserIn","family":"Kunst","given":"Claudia","display":"Kunst, Claudia","role":"aut"},{"family":"Nicolay","roleDisplay":"VerfasserIn","role":"aut","display":"Nicolay, Jan Peter","given":"Jan Peter"},{"family":"Müller-Schilling","roleDisplay":"VerfasserIn","given":"Martina","role":"aut","display":"Müller-Schilling, Martina"},{"given":"Karsten","display":"Gülow, Karsten","role":"aut","roleDisplay":"VerfasserIn","family":"Gülow"}],"name":{"displayForm":["Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller and Karsten Gülow"]},"relHost":[{"title":[{"title_sort":"FEBS journal","title":"The FEBS journal"}],"id":{"eki":["476538459"],"doi":["10.1111/(ISSN)1742-4658"],"zdb":["2172518-4"],"issn":["1742-4658"]},"disp":"Vereinigung der Europäischen Biochemischen GesellschaftenThe FEBS journal","note":["Gesehen am 24.03.25"],"part":{"text":"(2025), Seite 1-17","pages":"1-17","year":"2025","extent":"17"},"name":{"displayForm":["Federation of European Biochemical Societies"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford [u.a.]","dateIssuedKey":"2005","dateIssuedDisp":"2005-","publisher":"Wiley-Blackwell ; Blackwell"}],"pubHistory":["272.2005 -"],"corporate":[{"roleDisplay":"VerfasserIn","display":"Vereinigung der Europäischen Biochemischen Gesellschaften","role":"aut"}],"recId":"476538459"}],"language":["eng"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"2025"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1111/febs.70208"],"eki":["1939738083"]},"title":[{"title":"CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death","title_sort":"CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death"}],"recId":"1939738083","note":["Erstmals veröffentlicht: 1. August 2025","Gesehen am 30.10.2025"]} | ||
| SRT | |a TEUBNERJANCRISPRCAS92025 | ||